Detalhe da pesquisa
1.
Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens.
Antimicrob Agents Chemother
; 56(6): 2873-8, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22450969
2.
A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors.
J Antimicrob Chemother
; 67(1): 32-8, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21994909
3.
Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutations.
BMC Bioinformatics
; 12: 386, 2011 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21966893
4.
Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypes.
Antimicrob Agents Chemother
; 55(11): 5362-6, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21825300
5.
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.
J Antimicrob Chemother
; 66(12): 2827-30, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933786
6.
A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.
J Med Virol
; 81(10): 1702-9, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19697398
7.
Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
J Clin Virol
; 36(1): 43-9, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16563858
8.
HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.
PLoS One
; 7(4): e34708, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22496845
9.
Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.
AIDS Res Hum Retroviruses
; 28(10): 1285-93, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22417570
10.
A synthetic HIV-1 subtype C backbone generates comparable PR and RT resistance profiles to a subtype B backbone in a recombinant virus assay.
PLoS One
; 6(5): e19643, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21629677